Medpace Holdings (MEDP) Stock Statistics & Valuation Metrics

Medpace Holdings has a market cap or net worth of $293.48B. The enterprise value is $14.76K.

Medpace Holdings has 27,911,655 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medpace Holdings’s return on equity (ROE) is 0.98 and return on invested capital (ROIC) is 67.94%.

The current PE Ratio of Medpace Holdings is 34.6. Medpace Holdings’s PEG ratio is 1.82.

In the last 12 months, Medpace Holdings had revenue of 2.53B and earned 451.12M in profits. Earnings per share was 15.64.

In the last 12 months, operating cash flow was 752.66M and capital expenditures 11.57M, giving a free cash flow of 764.23M billion.

Medpace Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Medpace Holdings upcoming earnings date is Oct 26, 2026, After Close (Confirmed).

Medpace Holdings as a current ratio of 0.74, with Debt / Equity ratio of 27.68%

In the past 12 months, Medpace Holdings has paid 91.25M in taxes.

Medpace Holdings EV to EBITDA ratio is 27.97, with an EV/FCF ratio of 23.40.

Medpace Holdings has $502.69M in cash and marketable securities with $120.10M in debt, giving a net cash position of $382.59M billion.

Gross margin is 28.76%, with operating margin of 21.14%, and net profit margin of 17.83%.

The average price target for Medpace Holdings is $10,158.63, which is 11.43% higher than the current price. The consensus rating is Hold